{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:03:38Z","timestamp":1745622218321},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/mca.0000000000000329","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T21:26:34Z","timestamp":1450992394000},"page":"116-121","source":"Crossref","is-referenced-by-count":8,"title":["The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction"],"prefix":"10.1097","volume":"27","author":[{"given":"Sani N.","family":"Murat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alparslan","family":"Kurtul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim E.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikail","family":"Yarlioglues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alparslan","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Elcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1997.03550230069040","article-title":". Comparison of primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantative review.","volume":"278","author":"Weaver","year":"1997","journal-title":"J Am Med Assoc"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":". Clinical implications of the no reflow phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"H766","DOI":"10.1152\/ajpheart.00767.2001","article-title":"Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.","volume":"282","author":"Reffelmann","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1540-8183.2010.00561.x","article-title":"No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy.","volume":"23","author":"Rezkalla","year":"2010","journal-title":"J Interv Cardiol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":". Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.","volume":"36","author":"Morishima","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0735-1097(01)01779-X","article-title":"Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.","volume":"39","author":"Stone","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R7-9-20210204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0003319712474336","article-title":". No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives.","volume":"65","author":"Galasso","year":"2014","journal-title":"Angiology"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2014.03.005","article-title":". Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.","volume":"234","author":"Gur","year":"2014","journal-title":"Atherosclerosis"},{"key":"R9-9-20210204","first-page":"121","article-title":"The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention.","volume":"13","author":"Ramjane","year":"2008","journal-title":"Exp Clin Cardiol"},{"key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon.","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation"},{"key":"R11-9-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1476-5381.2009.00433.x","article-title":"Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.","volume":"159","author":"Becker","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2143\/AC.60.4.2004983","article-title":"Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis.","volume":"60","author":"Ilhan","year":"2005","journal-title":"Acta Cardiol"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/17482940701534800","article-title":". Procalcitonin in acute myocardial infarction.","volume":"10","author":"Kafkas","year":"2008","journal-title":"Acute Card Care"},{"key":"R15-9-20210204","first-page":"205","article-title":"Procalcitonin in patients with acute myocardial infarction.","volume":"114","author":"Remskar","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1007166521791","article-title":". Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.","volume":"25","author":"Buratti","year":"2001","journal-title":"Inflammation"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2143\/AC.62.2.2020233","article-title":"Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.","volume":"62","author":"Senturk","year":"2007","journal-title":"Acta Cardiol"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/147323001003800106","article-title":". Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome.","volume":"38","author":"Ataoglu","year":"2010","journal-title":"J Int Med Res"},{"key":"R19-9-20210204","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0003319715572218","article-title":". Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention.","volume":"66","author":"Kurtul","year":"2015","journal-title":"Angiology"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"Thrombolysis In Myocardial Infarction (TIMI) trial, phase I findings: TIMI study groups.","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjcard.2007.03.075","article-title":". Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.","volume":"100","author":"Hong","year":"2007","journal-title":"Am J Cardiol"},{"key":"R22-9-20210204","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":". 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R23-9-20210204","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1253\/circj.CJ-10-0638","article-title":". Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease.","volume":"75","author":"Sinning","year":"2011","journal-title":"Circ J"},{"key":"R24-9-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/13547501003675084","article-title":". Procalcitonin as a prognostic marker in patients with acute myocardial infarction.","volume":"15","author":"Kelly","year":"2010","journal-title":"Biomarkers"},{"key":"R25-9-20210204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.amjcard.2010.09.008","article-title":". Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty.","volume":"107","author":"Oduncu","year":"2011","journal-title":"Am J Cardiol"},{"key":"R26-9-20210204","doi-asserted-by":"crossref","first-page":"34","DOI":"10.6061\/clinics\/2015(01)07","article-title":"Increased neutrophil-to-lymphocyte ratio predicts persistent coronary no-flow after wire insertion in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"70","author":"Kurtul","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"R27-9-20210204","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjcard.2012.04.041","article-title":". Relation of neutrophillymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.","volume":"110","author":"Akpek","year":"2012","journal-title":"Am J Cardiol"},{"key":"R29-9-20210204","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc3910","article-title":"Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.","volume":"10","author":"Meisner","year":"2006","journal-title":"Crit Care"},{"key":"R30-9-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.CCM.0000134404.63292.71","article-title":"Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.","volume":"32","author":"Linscheid","year":"2004","journal-title":"Crit Care Med"},{"key":"R31-9-20210204","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1160\/TH04-02-0095","article-title":". CD14CD16 monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.","volume":"92","author":"Schlitt","year":"2004","journal-title":"Thromb Haemost"},{"key":"R32-9-20210204","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/head.12301","article-title":"Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.","volume":"54","author":"Raddant","year":"2014","journal-title":"Headache"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:12Z","timestamp":1620960012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201603000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000329","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}